Jodas Expoim Pvt. Ltd.

Jodas is a global, specialty, innovation-driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2008 in India, and today Jodas is a modern, research-driven organization that has quality and affordability at the heart of its activities. Our Core Therapeutic Segments: Anti Infectives (Injectables) Anti Cancer (Injectables & Orals) Contrast Media – Injectables Critical Care (Injectables & Orals) Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective, and affordable generic formulations to the market, touching millions of lives with good health. Jodas has approved products in 30+ countries with State-of-the-art world-class manufacturing facilities and has successfully commercialized 19.4 million Injectables in the year 2022, with unparalleled customer satisfaction. The future endeavor is to be a Global generic player, validating our commitment “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with specialty generic formulations of uncompromising quality.

Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals Limited is a professionally managed conglomerate of companies with interest in Pharmaceuticals, FCMG products and Builders Hardware. The value chain of our healthcare and trading business encompasses and controls the procurement, supply chain, distribution and point of sale aspects throughout all our verticals.

Sigachi Pharma

Sigachi Industries Limited is a leading Public Listed (NSE & BSE in India) Healthcare company working in domains of Pharmaceutical API & Excipients, Food & Nutrition, and Operations & Management industries. Founded in 1989, we've built a reputation for Pharmaceutical excellence in: •API & Intermediates: Our diversified portfolio includes active pharmaceutical ingredients (APIs) and their intermediates, supporting the development of life-saving medications. •Wide range of High-Performance Excipients: We're one of the world's largest manufacturers of cellulose-based excipients, playing a critical role in delivering effective and stable pharmaceuticals and nutraceuticals formulations. Unwavering Commitment to Quality & Compliance: •Our five multi-locational facilities are certified under EXCiPACT GMP, SGMP, HACCP, EDQM CEP, FSSAI, USFDA for intermediates, Kosher, Halal and ISO 9001:2015, guaranteeing the highest quality standards. •We have a global presence, supplying innovative and differentiated products to customers across Asia, Australia, the Americas, Europe, and the Middle East. A Value-Driven Culture: •At Sigachi, we foster employee creativity, expertise, and well-being, living by our motto of "Experience Excellence." •We're recognized as a Great Place to Work and hold a Silver Medal from Ecovadis for our strong commitment to environmental, social, and governance (ESG) practices. Join us in making a difference! •Visit our website: https://sigachi.com/ •Explore how Sigachi can be trusted partner for your formulations. •Connect with our team to discuss your specific needs. Follow us for industry insights, product updates, and company news!

celon laboratories limited

Celon Labs is a leader in the development and marketing of specialty products which serve niche therapy areas. Using in-house research & development capabilities, operational flexibility, manufacturing and regulatory expertise, Celon has taken a wide variety of products from laboratory to the market. Celon Laboratories Limited is a specialty-focused pharmaceutical company with core competencies in Oncology and Critical Care. We are commited to create better quality of life by being at the forefront of research, manufacturing and marketing of high quality formulations. Celon manufactures and markets a comprehensive portfolio of Oncology products and a vital portfolio of critical care products with a commitment to deliver wellness across the globe. Celon’s branded formulations business has domestic & international reach with focus on Indian & ROW markets. Our future endeavour in Global generics is all set to foray into the regulated markets. Celon fulfills an important need in the medical community as a provider of broad portfolio of injectable pharmaceutical products, including difficult to manufacture and urgently needed medical products. Our strategically designed business model creates a value chain that drives profitability and extends affordability to the end customer. Our focus is to become a global branded generic player with R&D expertise in extensive technology platforms, thereby delivering innovative drug delivery systems for enhancing treatment standards in the chosen therapy areas. Our constant eye for continuous upgradations in technologies and quality management systems guarantees that our products meet international standards of quality, safety and efficacy. In our journey ahead, we are all set to break new grounds, explore new frontiers and achieve new milestones in creating value in lifecare.

virchow biotech

Virchow Biotech (P) Ltd is an ISO 13485:2012 and WHO-GMP certified leading global player in Biopharma sector having around 20 years of operational experience and is situated at Hyderabad, India. We also have offices located in USA. Throughout the years, the company has been successful in Research and development, clinical trials, large-scale production and Commercialization of Plasma Products, Recombinants, Biologicals and Bio-Pharmaceuticals. With 1160 employees on the board, VBPL has an expansive infrastructure, which comprises of WHO cGMP and USFDA certified state-of-art clean-room manufacturing facilities and excellent fill-finish lines for PFS, vials, cartridges and lyophilized drug products. VBPL focuses on the manufacturing of a wide range of biologicals and bio-generics by genetic engineering, classical fermentation or extraction technologies. Apart from this, we also offer Contract Research and Manufacturing services, co-development of products for various markets and customers around the world. Virchow Biotech is the part of Virchow Group incorporated in 1981. Other group companies are leading manufacturers of Sulphamethoxazole, Ranitidine, Cephalosporins and various other APIs. VBPL's achievements include being the first company in the world to commercialize biogenerics of PDGF, Teriparatide, Pegylated Interferon and Rasburicase. VBPL has a wide product portfolio across Woundcare, Gynaecology, Urology, Oncology, Vaccines and Probiotics etc. Our mission is to provide high quality Biopharma products at an affordable price. Serving economically challenged patients across the globe through Biotechnology by extending our product base across various therapeutic segments.